RxSight (RXST) said Sunday it expects Q4 revenue of about $40.2 million, up roughly 41% from a year earlier.
Analysts polled by FactSet expect $40.4 million.
The company anticipates full-year 2024 revenue of $139.9 million. Analysts surveyed by FactSet expect $140 million.
For full-year 2025, RxSight expects revenue to come in between $185 million and $197 million. Analysts polled by FactSet expect $188 million.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.